Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled rhDNase for persistent obstructive childhood asthma
2006-002337-20Phase 3Active
- Sponsor
- Erasmus MC
- Start
- Jul 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of dornase alfa in asthma, sponsored by Erasmus MC. Primary endpoint: Change in FEF75. Started Jul 2006; status: active.
02
Drugs
dornase alfa
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-002337-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002337-20.